Trials / Recruiting
RecruitingNCT07193823
Sexual Dysfunction in Women With Multiple Sclerosis (MS)
Sexual Dysfunction Prevalence and Its Relationship With Various Factors in Women With Multiple Sclerosis
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 140 (estimated)
- Sponsor
- Ege University · Academic / Other
- Sex
- Female
- Age
- 25 Years – 50 Years
- Healthy volunteers
- Not accepted
Summary
Sexual dysfunction in women with multiple sclerosis (MS) is an important yet often overlooked problem. The primary objective of this study is to investigate the prevalence of sexual dysfunction in female patients diagnosed with MS. The secondary objective is to evaluate the relationship between sexual dysfunction and fatigue, depression, anxiety, overactive bladder symptoms, and cognitive dysfunction. For this purpose, the following validated instruments will be used: the Female Sexual Function Index (FSFI) to assess sexual dysfunction, the Brief International Cognitive Assessment for MS (BICAMS) to evaluate cognitive function, the Hospital Anxiety and Depression Scale (HADS) to assess depression and anxiety, the Fatigue Severity Scale (FSS) to measure fatigue, and the Overactive Bladder Questionnaire (OAB-V8) to evaluate overactive bladder symptoms.
Conditions
- Multiple Sclerosis
- Multiple Sclerosis (MS) - Relapsing-remitting
- Fatigue in Multiple Sclerosis
- Sexual Disfunction
- Cognitive Dysfunction
- Depression
- Anxiety
- Overactive Bladder
- Fatigue
Timeline
- Start date
- 2024-07-16
- Primary completion
- 2025-10-01
- Completion
- 2025-11-01
- First posted
- 2025-09-26
- Last updated
- 2025-09-26
Locations
1 site across 1 country: Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT07193823. Inclusion in this directory is not an endorsement.